Viewing Study NCT03267732


Ignite Creation Date: 2025-12-24 @ 9:59 PM
Ignite Modification Date: 2026-03-19 @ 11:51 AM
Study NCT ID: NCT03267732
Status: COMPLETED
Last Update Posted: 2019-04-05
First Post: 2017-08-24
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study to Evaluate the Pharmacokinetics in Participants After Dosing With Pegilodecakin (LY3500518)
Sponsor: Eli Lilly and Company
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Healthy Adult Subjects View
Keywords: